title: TAP gene transporter polymorphism in inflammatory bowel diseases.
abstract: BACKGROUND
  Many studies suggest the implication of genetic factors in inflammatory bowel diseases. Despite some associations with HLA genes, the lack of definite data may be due to ethnic variations, clinical heterogeneity, or the involvement of additional susceptibility genes beside or within the major histocompatibility complex (MHC), such as TAP genes. The aim of this study was to analyze in patients with ulcerative colitis (UC) or Crohn's disease (CD) the polymorphism of TAP genes that encode the proteins necessary for the transfer of antigenic peptides through the endoplasmic reticulum membrane.
  
  
  METHODS
  One hundred and one UC and 148 CD patients were compared with 173 unrelated healthy controls. Dimorphisms within the TAP1 and TAP2 alleles were analyzed by sequence-specific oligonucleotide typing.
  
  
  RESULTS
  No difference was found between patient groups and controls. However, when CD patients were classified on the basis of their responsiveness to steroid therapy, a significant decrease of TAP2 AA (*0101/*0101) genotype was found in CD patients who did not respond to steroid therapy (22.9% versus 43.7% in steroid responder group; Pc < 0.05; odds ratio = 2.6; 95% confidence limits (CL) = 1.2-5.9). These data appear independent of the distribution of HLA DRB1*01 or DRB1*03 alleles despite a significant linkage disequilibrium between these alleles and TAP2A.
  
  
  CONCLUSIONS
  This result suggests, despite the absence of arguments favoring a genetic susceptibility to CD, that the TAP2 gene or other genes located on chromosome 6 may be involved in the genetic heterogeneity of CD.
authors.affiliation: Dept. of Hepato-Gastroenterology, CHRU Pontchaillou, Lille, France.
authors.forename: D
authors.initials: D
authors.lastname: Heresbach
authors.forename: M
authors.initials: M
authors.lastname: Alizadeh
authors.forename: J F
authors.initials: JF
authors.lastname: Bretagne
authors.forename: A
authors.initials: A
authors.lastname: Dabadie
authors.forename: J F
authors.initials: JF
authors.lastname: Colombel
authors.forename: M
authors.initials: M
authors.lastname: Pagenault
authors.forename: N
authors.initials: N
authors.lastname: Heresbach-Le Berre
authors.forename: B
authors.initials: B
authors.lastname: Genetet
authors.forename: M
authors.initials: M
authors.lastname: Gosselin
authors.forename: G
authors.initials: G
authors.lastname: Semana
mesh_terms: D000071181:ATP Binding Cassette Transporter, Subfamily B, Member 2; D000071450:ATP Binding Cassette Transporter, Subfamily B, Member 3; D018528:ATP-Binding Cassette Transporters / Q000235:genetics*; D000328:Adult; D016022:Case-Control Studies; D002896:Chromosomes, Human, Pair 6; D003093:Colitis, Ulcerative / Q000235:genetics*; D003424:Crohn Disease / Q000235:genetics*; D005260:Female; D005787:Gene Frequency; D005802:Genes, MHC Class II; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D011110:Polymorphism, Genetic
chemical_list: D000071181:ATP Binding Cassette Transporter, Subfamily B, Member 2; D000071450:ATP Binding Cassette Transporter, Subfamily B, Member 3; D018528:ATP-Binding Cassette Transporters; D005819:Genetic Markers; C073119:TAP1 protein, human; C071692:TAP2 protein, human